In vitro cytostatic activity and DNA-interaction of the new liver organotropic complex chloro-bis-cholylglycinate-platinum(II)

Anticancer Research

Volumn 18, Issue 3 A, 1998, Pages 1641-1647

  Marin, Jose J G ^a   Palomero, Maria F ^a   Herrera, Maria C ^a   Macias, Rocio I R ^a   Criado, Julio J ^a   Serrano, Maria A ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Bile acid; Cancer; Chemotherapy; Glycocholate; Proliferation; Tumor

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORO BIS CHOLYLGLYCINATE PLATINUM; CYTOSTATIC AGENT; ETHIDIUM BROMIDE; PLATINUM DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; COLON ADENOCARCINOMA; CONTROLLED STUDY; CYTOSTASIS; DNA DENATURATION; DNA SYNTHESIS INHIBITION; DRUG DNA INTERACTION; ELECTROPHORETIC MOBILITY; HEPATOMA CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SCATCHARD PLOT;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL LINE; COLONIC NEOPLASMS; DNA REPLICATION; DNA, NEOPLASM; ETHIDIUM; HUMANS; KINETICS; LEUKEMIA L1210; LIVER NEOPLASMS, EXPERIMENTAL; MICE; NUCLEIC ACID DENATURATION; ORGANOMETALLIC COMPOUNDS; RATS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0031829706     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Canon JL, Humblet Y, Symann M: Resistance to cisplatin. How to deal with the problem?. Eur J Cancer 26: 1-3, 1990.
2. Konno T: Targeting chemotherapy for hepatoma - Arterial administration of anticancer drugs dissolved in lipiodol. Eur J Cancer 28: 403-409, 1992.
3. Azer SA, Stacey NH: Current concepts of hepatic uptake, intracellular transport and biliary secretion of bile acids: Physiological basis and pathophysiological changes in cholestatic liver dysfunction. J Gastroenterol Hepatol 11: 396-407, 1996.
4. Betebenner DA, Carney PL, Zimmer AM, Kazikiewicz JM: Hepatobiliary delivery of polyaminopolycarboxylate chelates: Synthesis and characterization of a cholic acid conjugate of EDTA and biodistribution and imaging studies with its indium- 111 chelate. Bioconjugate Chem 2: 117-123, 1991.
5. Ho NFH: Utilizing bile acid carrier mechanisms to enhance liver and small intestine absorption. Ann NY Acad Sci 907: 315-329, 1987.
6. Kramer W, Wess G, Enhsen A, Bock K, Falk E, Hoffmann A, Neckermann G, Gantz D, Schulz S, Nickau L, Petzinger E, Turley S, Dietschy JM: Bile acid derived HMG-CoA reductase inhibitors. Biochim Biophys Acta 1227: 137-154, 1994.
7. Kramer W, Wess G, Schubert G, Bickel M, Girbig F, Gutjahr U, Kowalewski S, Baringhaus KH, Enhsen A, Glombik H, Mullner S, Neckermann G, Schulz S, Petzinger E: Liver-specific drug targeting by coupling to bile acids. J Biol Chem 267: 18598-18604, 1992.
8. Stephan ZF, Yurachek EC, Sharif R, Wasvary JM, Steele RE, Howes C: Reduction of cardiovascular and thyroxine-suppressing activities of L-T3 by liver targeting with cholic acid. Biochem Pharmacol 43: 1969-1974, 1992.
9. Carey MC: Physical-chemical properties of bile acids and their salts. In: Danielsson H, Sjovall J, eds. Steroids and Bile Acids. Amsterdam, Elseviers Science Publishers, 345-403, 1985.
10. Maeda M, Takasuka N, Suga T, Sasaki T: New antitumor platinum(II) complexes with both lipophilicity and water miscibility. Japan J Cancer Res 81: 567-569, 1990.
11. Marin JJG, Herrera MC, Palomero MF, Macias RIR, Monte MJ, El-Mir MY, Villanueva GR: Rat liver transport and biotransformation of a cytostatic complex of bis-cholylglycinate and platinum(II). J Hepatol (in press), 1998.
12. Criado JJ, Herrera MC, Palomero MF, Medarde M, Rodriguez E, Marin JJG: Synthesis and characterization of a new bile acid and platinum(II) complex with cytostatic activity. J Lipid Res 38: 1022-1032, 1997.
13. Donaldson KL, Goolsby GL, Wahl AF: Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle. Int J Cancer 57: 847-855, 1994.
14. Sundquist WI, Lippard SJ: The coordination chemistry of platinum anticancer drugs and related compounds with DNA. Coordin Chem Rev 100: 293-322, 1990.
15. Labarca C, Paigen K: A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102: 344-352, 1980.
16. Markwell MAK, Hass SM, Beiber LL, Tolbert NE: A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87: 206-210, 1978.
17. Church KM, Moore TA, Luckey S, Schaeper M, Chase K: Synthesis and DNA binding properties of tryptophan-linked monocationic netropsin analogues. Bioorg Med Chem Lett 3: 2623-2626, 1993.
18. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. New York, Cold Spring Harbor Laboratory Press, 1989.
19. Mital R, Srivastava TS: Synthesis, characterization, and DNA binding studies of some mixed- ligand platinum(II) complexes of 1,10-phenanthroline and amino acids. J Inorg Biochem 40: 111-120, 1990.
20. Thorne HV. Electrophoretic separation of polyoma virus DNA from host cell DNA. Virology 29: 234-239, 1966.
21. Johnson PH, Grossman LI: Electrophoresis of DNA in agarose gels. Optimizing separations of conformational isomers of double-and single-stranded DNAs. Biochemistry 16: 4217-4225, 1977.
22. Horacek P, Drobnik J: Interaction of cis-dichlorodiammineplatinum (II) with DNA. Biochim Biophys Acta 254: 341-347, 1971.
23. Pinto AL, Lippard SJ. Binding of the antitumor drug cis-diamminedichoroplatinum(II) (cisplatin) to DNA. Biochim Biophys Acta 780: 167-180, 1985.
24. Kramer W, Wess G: Bile acid transport systems as pharmaceutical targets. Eur J Clin Invest 26: 715-732, 1996.
25. Marin JJG, Herrera MC, Palomero F, Macias RIR, Monte MJ, Villanueva GR, El-Mir MY, Serrano MA, Criado JJ: In vivo distribution, toxicity and cytostatic capacity of platinated bile acid analogs. Hepatology 24: 372A, 1996.
26. Meijer DKF: Drug targeting to the liver with bile acids. The Trojan Horse resurrected. Hepatology 17: 945-948, 1993.
27. Buscher HP, Gerok W, Kollinger M, Kurz G, Muller M, Nolle A, Schneider S: Transport systems for amphipathic compounds in normal and neoplastic hepatocytes. Adv Enzyme Regul 27: 173-192, 1988.
28. Kullak-Ublick GA, Beuers U, Paumgartner G: Molecular and functional characterization of bile acid transport in human hepatoblastoma HepG2 cells. Hepatology 23: 1053-1060, 1996.
29. Bravo P, Bender V, Cassio D: Vectorial transport of cholylglycylamido-fluorescein by the polarized hepatic hybrid WIF-B and WIF-B9 cells. Cell Biol Toxicol 2: 26, 1996.
30. Mivazaki M, Namba M: Hepatocellular Carcinomas. In: Hay RJ, Park JG, eds. Atlas of Human Tumor Cell Line. San Diego. Academic Press Inc. 185-212, 1994.